Skip to content

Innovative Mouthwash in School-Aged Children With Fixed Orthodontic Appliances

Laboratory and Clinical Evaluation of an Innovative Mouthwash in School-Aged Children With Fixed Orthodontic Appliances

Status
Not yet recruiting
Phases
Unknown
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT07710144
Enrollment
90
Registered
2026-07-17
Start date
2026-09-01
Completion date
2028-05-31
Last updated
2026-07-17

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Dental Plaque Accumulation, Halitosis, Plaque-Induced Gingivitis

Brief summary

Fixed metal orthodontic appliances create additional plaque-retentive areas around brackets, archwires and ligatures, making mechanical plaque control more difficult in children and adolescents. Increased plaque accumulation may contribute to gingival inflammation, bleeding, halitosis and early enamel changes. Therefore, adjunctive preventive agents, including mouthwashes, may be clinically useful as part of a comprehensive oral hygiene program during fixed orthodontic treatment. The aim of the study is to evaluate the clinical effectiveness and tolerability of a test mouthwash in children and adolescents with fixed orthodontic appliances by monitoring plaque accumulation, gingival inflammation, gingival bleeding and halitosis.

Interventions

OTHERTest mouthwash

Participants rinsed with a 15 ml prototype chlorhexidine-free pediatric mouthwash for 30-60 s twice daily for 21 days as an adjunct to standard oral hygiene.

OTHERChlorhexidine-containing mouthwash

Participants rinsed with a 15 ml chlorhexidine-containing mouthwash for 30-60 s twice daily for 21 days as an adjunct to standard oral hygiene.

OTHERPlacebo mouthwash

Participants rinsed with a 15 ml placebo mouthwash for 30-60 s twice daily for 21 days as an adjunct to standard oral hygiene.

Sponsors

Plovdiv Medical University
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
PREVENTION
Masking
DOUBLE (Subject, Outcomes Assessor)

Intervention model description

This was a randomized, parallel-group interventional study with three arms. Participants were assigned to receive either a prototype chlorhexidine-free pediatric mouthwash, a chlorhexidine-containing mouthwash, or a placebo mouthwash for 21 days as an adjunct to standard oral hygiene.

Eligibility

Sex/Gender
ALL
Age
12 Years to 17 Years
Healthy volunteers
No

Inclusion criteria

1. Participants aged 12 to 17 years. 2. Presence of fixed metal orthodontic appliances placed at least 6 months before enrollment. 3. Generalized plaque-induced gingivitis. 4. Full Mouth Bleeding Score greater than 30%. 5. Gingival Index greater than 0.95 according to Loe and Silness. 6. Written informed consent obtained from a parent or legal guardian. 7. Participant willingness to comply with the study protocol.

Exclusion criteria

1. Refusal to participate or withdrawal of informed consent. 2. Non-compliance with the intervention regimen or inability to attend follow-up visits. 3. Development of an adverse reaction or condition requiring discontinuation. 4. Antibiotic or antimicrobial therapy during follow-up if it may affect the study outcomes. 5. Presence of concomitant systemic diseases. 6. Current systemic medication intake that could influence oral health or inflammatory status. 7. Use of systemic or local antimicrobial agents during the previous 3 months, including mouthwashes, gels, chewing gums or other local oral agents. 8. Known allergy or hypersensitivity to any component of the tested mouthwash formulations. 9. Use of removable orthodontic appliances only. Inability or unwillingness to follow the study instructions.

Design outcomes

Primary

MeasureTime frameDescription
Orthodontic Plaque Index (OPI)Baseline, day 7, day 21, and 3 monthsThe Orthodontic Plaque Index focuses on the areas around the bracket, which represents an additional plaque-retentive factor. The dentition is divided into sextants and plaque accumulation is scored from 0 to 4. The mesial, distal, incisal and cervical areas around each bracket are evaluated. The highest score among all sextants defines the oral hygiene level and identifies the need for preventive measures. Registry field data Code 0 No plaque accumulation is detected. Code 1 Plaque accumulation is detected on one tooth surface around the bracket base. Code 2 Plaque accumulation is detected on two tooth surfaces around the bracket base. Code 3 Plaque accumulation is detected on three tooth surfaces around the bracket base; increased risk of caries and gingivitis is assumed. Code 4 Plaque accumulation is detected on all tooth surfaces around the bracket base and/or gingival inflammation is present.
Gingival Index (Loe & Silness)Baseline, day 7, day 21, and 3 monthsThe index evaluates color, contour and bleeding of the gingival tissues. A World Health Organization (WHO) 621 periodontal probe is used to examine the gingival sulcus, and bleeding is recorded within 10 seconds. Code 0 Normal gingiva. Code 1 Mild inflammation: slight color change and slight edema, without bleeding on probing. Code 2 Moderate inflammation: redness, edema and glazing, with bleeding on probing. Code 3 Severe inflammation: marked redness and edema, ulceration and tendency to spontaneous bleeding.
Full Mouth Bleeding Score (FMBS)Baseline, day 7, day 21, and 3 monthsFMBS assesses provoked bleeding from the gingival sulcus using a WHO 621 periodontal probe. Bleeding is recorded within 10 seconds and marked as present (+) or absent (-). The index is calculated as the percentage of gingival sites with provoked bleeding from all examined sites for each child.
Full Mouth Plaque Score (FMPS)Baseline, day 7, day 21, and 3 monthsDental plaque accumulation was assessed using the Full Mouth Plaque Score. The presence of visible plaque was recorded on tooth surfaces, and the result was expressed as the percentage of plaque-positive sites. Lower percentages indicate improved plaque control.

Secondary

MeasureTime frameDescription
Halitosis AssessmentBaseline, day 7, day 21, and 3 monthsHalitosis was assessed by gas chromatography using OralChroma™. Volatile sulfur compounds were measured, including hydrogen sulfide, methyl mercaptan and dimethyl sulfide.

Countries

Bulgaria

Contacts

CONTACTTanya Zalamova
tanya.zalamova@mu-plovdiv.bg00359878752567
CONTACTAni Belcheva, PhD
abeltcheva@gmail.com
PRINCIPAL_INVESTIGATORTanya Zalamova

Plovdiv Medical University

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Jul 18, 2026